IP Library Granted Patent US 10,550,375
Granted Patent B2
US 10,550,375 · App. 15/116,281 · Granted Feb 4, 2020

Polypeptide having xylanase activity

Inventors: Rikke Hoeegh Lorentsen (Randers, DK); Susan Arent Lund (Braband, DK); Svend Haaning (Galten, DK); Igor Nikolaev (Nordwijk, NL); Sharief Barends (Voorschoten, NL); Jan Hendrick A Van Tuijl (Zoetermeer, NL); Bart Koops (Pijnacker, NL)
Assignee: DuPont Nutrition Biosciences ApS
C12N9/2482A23K20/189A61K38/47C12C5/004C12C7/01C12P19/04C12P19/14C12Y302/01008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,550,375
App. No.
15/116,281
Granted
Feb 4, 2020
Kind
B2
Abstract

The present invention relates to an isolated polypeptide having xylanase activity, selected from the group consisting of: a) a polypeptide comprising an amino acid sequence having at least 87% identity with SEQ ID NO: 1; b) a polypeptide encoded by a polynucleotide having at least 87% identity with SEQ ID NO:2; or c) a fragment of a polypeptide of a) or b) which fragment has xylanase activity.

Claims (19)

1. A polypeptide having xylanase activity, selected from the group consisting of:

(a) a polypeptide comprising an amino acid sequence having at least 94% identity with SEQ ID NO: 1; or

(b) a polypeptide encoded by a polynucleotide having at least 94% identity with SEQ ID NO:2.

2. The polypeptide according to claim 1 , wherein the polypeptide comprises the amino acid sequence of SEQ ID No. 1.

3. The polypeptide of claims 1 or 2 wherein the polypeptide is encoded by the polynucleotide of SEQ ID No. 2.

4. The polypeptide of claims 1 or 2 , wherein the polypeptide is an endo-1,4-β-xylanase.

5. The polypeptide of claims 1 or 2 , wherein the polypeptide has at least 50% residual activity of xylanase activity after incubation at 65° C. for 10 minutes at pH 6 and/or has at least 80% residual activity of xylanase activity after incubation at 61° C. for 10 minutes at pH 6.

6. The polypeptide according to claim 1 , wherein the polypeptide has a residual activity of at least 70% when incubated with 0.2 mg/ml pepsin in a buffered solution at pH 3.5 for two hours at a temperature of 40° C.

7. The polypeptide according to claim 1 , wherein the polypeptide solubilizes arabinoxylans without increasing viscosity in a reaction medium.

8. A feed or feedstuff comprising the polypeptide of claims 1 or 2 .

9. A method for producing the polypeptide of claims 1 or 2 comprising (a) cultivating a host cell comprising a polynucleotide having at least 94% identity with SEQ ID No. 2 under conditions conducive for production of the polypeptide; and (b) recovering the polypeptide.

10. The method according to claim 9 wherein the polypeptide produced is isolated and/or purified.

11. A method for solubilizing arabinoxylan in a xylan-containing material by contacting the xylan-containing material with the polypeptide of claims 1 or 2 .

12. The method of claim 11 wherein the arabinoxylan is insoluble arabinoxylan (AXinsol).

13. The method of claim 11 wherein the xylan-containing material is selected from one or more of the group consisting of: a feed or feedstuff; a feed component; a grain-based material; a mash; a wort; a malt; malted barley; an adjunct, a barley mash; and a cereal flour.

14. The method of claim 13 wherein the feed or feedstuff or feed component comprises or consists of corn, Distillers Dried Grain Solubles (DDGS), corn based Distillers Dried Grain Solubles (cDDGS), wheat, wheat bran or a combination thereof.

15. The method of claim 11 wherein the polypeptide is used in combination with one or more of the enzymes selected from the group consisting of endoglucanases (E.C. 3.2.1.4) celliobiohydrolases (E.C. 3.2.1.91), β-glucosidases (E.C. 3.2.1.21), cellulases (E.C. 3.2.1.74), lichenases (E.C. 3.2.1.73), lipases (E.C. 3.1.1.3), lipid acyltransferases (E.C. 2.3.1.x), phospholipases (E.C. 3.1.1.4, E.C. 3.1.1.32 and E.C. 3.1.1.5), 6-phytase (E.C. 3.1.3.26) 3-phytase (E.C. 3.1.3.8), amylases, alpha-amylases (E.C. 3.2.1.1), xylanases (E.C. 3.2.1.8, E.C. 3.2.1.32, E.C. 3.2.1.37, E.C. 3.2.1.72, and E.C. 3.2.1.136), glucoamylases (E.C. 3.2.1.3), hemicellulases, subtilisin (E.C. 3.4.21.62) bacillolysin (E.C. 3.4.24.28) alkaline serine proteases (E.C. 3.4.21.x) akeratinases (E.C. 3.4.x.x), debranching enzymes, cutinases, esterases and β-mannanase (E.C. 3.2.1.78).

16. The method of claim 12 wherein the polypeptide is used in combination with one or more of the enzymes selected from the group consisting of endoglucanases (E.C. 3.2.1.4) celliobiohydrolases (E.C. 3.2.1.91), β-glucosidases (E.C. 3.2.1.21), cellulases (E.C. 3.2.1.74), lichenases (E.C. 3.2.1.73), lipases (E.C. 3.1.1.3), lipid acyltransferases (E.C. 2.3.1.x), phospholipases (E.C. 3.1.1.4, E.C. 3.1.1.32 and E.C. 3.1.1.5), 6-phytase (E.C. 3.1.3.26) 3-phytase (E.C. 3.1.3.8), amylases, alpha-amylases (E.C. 3.2.1.1), xylanases (E.C. 3.2.1.8, E.C. 3.2.1.32, E.C. 3.2.1.37, E.C. 3.2.1.72, and E.C. 3.2.1.136), glucoamylases (E.C. 3.2.1.3), hemicellulases, subtilisin (E.C. 3.4.21.62) bacillolysin (E.C. 3.4.24.28) alkaline serine proteases (E.C. 3.4.21.x) akeratinases (E.C. 3.4.x.x), debranching enzymes, cutinases, esterases and β-mannanase (E.C. 3.2.1.78).

17. The method of claim 13 wherein the polypeptide is used in combination with one or more of the enzymes selected from the group consisting of endoglucanases (E.C. 3.2.1.4) celliobiohydrolases (E.C. 3.2.1.91), β-glucosidases (E.C. 3.2.1.21), cellulases (E.C. 3.2.1.74), lichenases (E.C. 3.2.1.73), lipases (E.C. 3.1.1.3), lipid acyltransferases (E.C. 2.3.1.x), phospholipases (E.C. 3.1.1.4, E.C. 3.1.1.32 and E.C. 3.1.1.5), 6-phytase (E.C. 3.1.3.26) 3-phytase (E.C. 3.1.3.8), amylases, alpha-amylases (E.C. 3.2.1.1), xylanases (E.C. 3.2.1.8, E.C. 3.2.1.32, E.C. 3.2.1.37, E.C. 3.2.1.72, and E.C. 3.2.1.136), glucoamylases (E.C. 3.2.1.3), hemicellulases, subtilisin (E.C. 3.4.21.62) bacillolysin (E.C. 3.4.24.28) alkaline serine proteases (E.C. 3.4.21.x) akeratinases (E.C. 3.4.x.x), debranching enzymes, cutinases, esterases and β-mannanase (E.C. 3.2.1.78).

Assignments (4)
CHANGE OF NAME Recorded Feb 6, 2024
From: DUPONT NUTRITION BIOSCIENCES APS
To: INTERNATIONAL N&H DENMARK APS
Reel/Frame 066494/0814 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2017
From: GENENCOR INTERNATIONAL B.V.
To: DUPONT NUTRITION BIOSCIENCES APS
Reel/Frame 044285/0676 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2017
From: LORENTSEN, RIKKE HOEEGH; LUND, SUSAN ARENT; HAANING, SVEND
To: DUPONT NUTRITION BIOSCIENCES APS
Reel/Frame 043752/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2017
From: NIKOLAEV, IGOR; BARENDS, SHARIEF; VAN TUIJL, JAN HENDRIK A; KOOPS, BART C
To: GENENCOR INTERNATIONAL B.V.
Reel/Frame 043752/0645 →
Priority Claims (1)
GB 1401699.2 · Jan 31, 2014 · national
Continuity (1)
Related Publication 20170009220A1 · Jan 12, 2017